Comparative Pharmacology
Head-to-head clinical analysis: AMOXICILLIN versus KLEBCIL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMOXICILLIN versus KLEBCIL.
AMOXICILLIN vs KLEBCIL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Amoxicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and activating autolytic enzymes.
Klebcillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and activating autolytic enzymes.
250-500 mg orally every 8 hours or 500-875 mg orally every 12 hours; for severe infections, up to 1 g orally every 8 hours.
KLEBCIL (ceftazidime-avibactam) 2.5 g (ceftazidime 2 g + avibactam 0.5 g) IV every 8 hours infused over 2 hours.
None Documented
None Documented
Clinical Note
moderateAmoxicillin + Acemetacin
"Amoxicillin may decrease the excretion rate of Acemetacin which could result in a higher serum level."
Clinical Note
moderateAmoxicillin + Probenecid
"The serum concentration of Probenecid can be increased when it is combined with Amoxicillin."
Clinical Note
moderateAmoxicillin + Fluconazole
"The metabolism of Fluconazole can be decreased when combined with Amoxicillin."
Clinical Note
moderateAmoxicillin + Clotrimazole
Terminal elimination half-life: 1-1.5 hours in normal renal function. Prolonged to 7-20 hours in end-stage renal disease.
2-3 hours (prolonged to 30-60 hours in severe renal impairment; adjust dosing)
Renal: 60-80% unchanged via glomerular filtration and tubular secretion. Biliary: up to 20% excreted in bile. Fecal: minimal.
Primarily renal (70-80% unchanged); minor biliary/fecal (15-20%)
Category A/B
Category C
Penicillin Antibiotic
Penicillin Antibiotic
"The metabolism of Clotrimazole can be decreased when combined with Amoxicillin."